Efficacy and Cardiovascular Safety of DPP-4 Inhibitors

Subrahmanyan, NA; Koshy, RM; Jacob, K; Pappachan, JM

Pappachan, JM (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Dept Endocrinol & Metab, Preston PR2 9HT, Lancs, England.

CURRENT DRUG SAFETY, 2021; 16 (2): 154

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors or gliptins belong to the class of incretin mimetics. These drugs have been available on the market for the ......

Full Text Link